journal article Open Access Jun 30, 2025

Unlocking Superior MFH Performance Below Hergt’s Biological Safety Limit: SPION-Based Magnetic Nanoplatforms Deliver High Heating Efficiency at Low AMF

Bioengineering Vol. 12 No. 7 pp. 715 · MDPI AG
View at Publisher Save 10.3390/bioengineering12070715
Abstract
Superparamagnetic iron oxide nanoparticles (SPIONs) have gained significant attention for Magnetic Fluid Hyperthermia (MFH)-based cancer therapy. However, achieving high heating efficiency under a biologically safe Alternating Magnetic Field (AMF) remains a challenge. This study investigates the synthesis and optimization of SPIONs encapsulated in TPGS-stabilized PLGA nanoparticles (TPS-NPs) using a modified single emulsion solvent evaporation (M-SESE) method. The aim was to achieve efficient magnetic heating under biologically safe AMF conditions while maintaining biocompatibility and colloidal stability, making these magnetic nanoplatforms suitable for MFH-based cancer treatment. TPS-NPs were characterized using various techniques, including Dynamic Light Scattering (DLS), Atomic Force Microscopy (AFM), Transmission Electron Microscopy (TEM), and Superconducting Quantum Interference Device (SQUID) magnetometry, to evaluate their hydrodynamic size (Dh), zeta potential (ζ), encapsulation efficiency, and superparamagnetic properties. Calorimetric MFH studies demonstrated superior heating efficiency, with Specific Absorption Rate (SAR) and Intrinsic Loss Power (ILP) values optimized at an AMF of 4.1 GAm−1s−1, remaining within Hergt’s biological safety limit (~5 GAm−1s−1). These findings suggest that SPION-encapsulated TPS-NPs exhibit enhanced heat induction, making them promising candidates for MFH-based cancer therapy. The study highlights their potential as multifunctional nanoplatforms for magnetic hyperthermia therapy, paving the way for clinical translation in oncology for advanced cancer treatment.
Topics

No keywords indexed for this article. Browse by subject →

References
68
[1]
Sung "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA" Cancer J. Clin. (2021) 10.3322/caac.21660
[2]
Basak, D., Arrighi, S., Darwiche, Y., and Deb, S. (2021). Comparison of Anticancer Drug Toxicities: Paradigm Shift in Adverse Effect Profile. Life, 12. 10.3390/life12010048
[3]
Mechanisms of Multidrug Resistance in Cancer Chemotherapy

Karol Bukowski, Mateusz Kciuk, Renata Kontek

International Journal of Molecular Sciences 10.3390/ijms21093233
[4]
Challenges and Opportunities Associated With Drug Delivery for the Treatment of Solid Tumors

Teona Paresishvili, Zurab Kakabadze

Oncology Reviews 2023 10.3389/or.2023.10577
[5]
Chauhan "Strategies for Advancing Cancer Nanomedicine" Nat. Mater. (2013) 10.1038/nmat3792
[6]
Spoială, A., Ilie, C.-I., Motelica, L., Ficai, D., Semenescu, A., Oprea, O.-C., and Ficai, A. (2023). Smart Magnetic Drug Delivery Systems for the Treatment of Cancer. Nanomaterials, 13. 10.3390/nano13050876
[7]
You "Recent Advances in PLGA Polymer Nanocarriers for Ovarian Cancer Therapy" Front. Oncol. (2025) 10.3389/fonc.2025.1526718
[8]
Kapoor "PLGA: A Unique Polymer for Drug Delivery" Ther. Deliv. (2015) 10.4155/tde.14.91
[9]
Hergt "Magnetic Particle Hyperthermia: Nanoparticle Magnetism and Materials Development for Cancer Therapy" J. Phys. Condens. Matter (2006) 10.1088/0953-8984/18/38/s26
[10]
Zhang "Advances in Magnetic Induction Hyperthermia" Front. Bioeng. Biotechnol. (2024) 10.3389/fbioe.2024.1432189
[11]
Jordan "Roland Felix Magnetic Fluid Hyperthermia (MFH): Cancer Treatment with AC Magnetic Field Induced Excitation of Biocompatible Superparamagnetic Nanoparticles" J. Magn. Magn. Mater. (1999) 10.1016/s0304-8853(99)00088-8
[12]
Janko "Functionalized Superparamagnetic Iron Oxide Nanoparticles (SPIONs) as Platform for the Targeted Multimodal Tumor Therapy" Front. Oncol. (2019) 10.3389/fonc.2019.00059
[13]
Mahmoudi "Superparamagnetic Iron Oxide Nanoparticles: Promises for Diagnosis and Treatment of Multiple Sclerosis" ACS Chem. Neurosci. (2011) 10.1021/cn100100e
[14]
Li "Facile Preparation of Multifunctional Superparamagnetic PHBV Microspheres Containing SPIONs for Biomedical Applications" Sci. Rep. (2016) 10.1038/srep23140
[15]
Rajan "Recent Advancements and Clinical Aspects of Engineered Iron Oxide Nanoplatforms for Magnetic Hyperthermia-Induced Cancer Therapy" Mater. Today Bio (2024) 10.1016/j.mtbio.2024.101348
[16]
Etemadi "Iron Oxide Nanoparticles: Physicochemical Characteristics and Historical Developments to Commercialization for Potential Technological Applications" ACS Biomater. Sci. Eng. (2021) 10.1021/acsbiomaterials.1c00938
[17]
Magnetic particle hyperthermia—biophysical limitations of a visionary tumour therapy

Rudolf Hergt, Silvio Dutz

Journal of Magnetism and Magnetic Materials 2007 10.1016/j.jmmm.2006.10.1156
[18]
Liu "Comprehensive Understanding of Magnetic Hyperthermia for Improving Antitumor Therapeutic Efficacy" Theranostics (2020) 10.7150/thno.40805
[19]
Obaidat, I.M., Narayanaswamy, V., Alaabed, S., Sambasivam, S., and Muralee Gopi, C.V.V. (2019). Principles of Magnetic Hyperthermia: A Focus on Using Multifunctional Hybrid Magnetic Nanoparticles. Magnetochemistry, 5. 10.3390/magnetochemistry5040067
[20]
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications

L. Harivardhan Reddy, José L. Arias, Julien Nicolas et al.

Chemical Reviews 2012 10.1021/cr300068p
[21]
Mehata, A.K., Setia, A., Vikas, V., Malik, A.K., Hassani, R., Dailah, H.G., Alhazmi, H.A., Albarraq, A.A., Mohan, S., and Muthu, M.S. (2023). Vitamin E TPGS-Based Nanomedicine, Nanotheranostics, and Targeted Drug Delivery: Past, Present, and Future. Pharmaceutics, 15. 10.3390/pharmaceutics15030722
[22]
Cui "Dual-Targeting Magnetic PLGA Nanoparticles for Codelivery of Paclitaxel and Curcumin for Brain Tumor Therapy" ACS Appl. Mater. Interfaces (2016) 10.1021/acsami.6b10175
[23]
Chen "Formulation, Characterization and Evaluation of Curcumin-Loaded PLGA-TPGS Nanoparticles For Liver Cancer Treatment" Drug Des. Devel. Ther. (2019) 10.2147/dddt.s211748
[24]
Sebastian "Co-Encapsulation of Superparamagnetic Nanoparticles and Doxorubicin in PLGA Nanocarriers: Development, Characterization and in Vitro Antitumor Efficacy in Glioma Cells" Eur. J. Pharm. Biopharm. (2019) 10.1016/j.ejpb.2019.10.004
[25]
Sudame "Symbiotic Thermo-Chemotherapy for Enhanced HepG2 Cancer Treatment via Magneto-Drugs Encapsulated Polymeric Nanocarriers" Colloids Surf. A Physicochem. Eng. Asp. (2020) 10.1016/j.colsurfa.2020.125355
[26]
Das "Biofunctionalized, Phosphonate-Grafted, Ultrasmall Iron Oxide Nanoparticles for Combined Targeted Cancer Therapy and Multimodal Imaging" Small (2009) 10.1002/smll.200901219
[27]
Kandasamy "Multifunctional Magnetic-Polymeric Nanoparticles Based Ferrofluids for Multi-Modal in Vitro Cancer Treatment Using Thermotherapy and Chemotherapy" J. Mol. Liq. (2019) 10.1016/j.molliq.2019.111549
[28]
Riedinger "Subnanometer Local Temperature Probing and Remotely Controlled Drug Release Based on Azo-Functionalized Iron Oxide Nanoparticles" Nano Lett. (2013) 10.1021/nl400188q
[29]
Kallumadil "Suitability of Commercial Colloids for Magnetic Hyperthermia" J. Magn. Magn. Mater. (2009) 10.1016/j.jmmm.2009.02.075
[30]
Kandasamy "Systematic Investigations on Heating Effects of Carboxyl-Amine Functionalized Superparamagnetic Iron Oxide Nanoparticles (SPIONs) Based Ferrofluids for in Vitro Cancer Hyperthermia Therapy" J. Mol. Liq. (2018) 10.1016/j.molliq.2018.02.029
[31]
Maity "Studies of Magnetite Nanoparticles Synthesized by Thermal Decomposition of Iron (III) Acetylacetonate in Tri(Ethylene Glycol)" J. Magn. Magn. Mater. (2009) 10.1016/j.jmmm.2009.05.020
[32]
Maity "Synthesis of Magnetite Nanoparticles via a Solvent-Free Thermal Decomposition Route" J. Magn. Magn. Mater. (2009) 10.1016/j.jmmm.2008.11.013
[33]
Shang "Fabrication, Characterization, and Controlled Release of Eprinomectin from Injectable Mesoporous PLGA Microspheres" RSC Adv. (2015) 10.1039/c5ra12262g
[34]
Yu "Core/Shell PLGA Microspheres with Controllable in Vivo Release Profile via Rational Core Phase Design" Artif. Cells Nanomed. Biotechnol. (2018) 10.1080/21691401.2018.1443940
[35]
Wang "The Mechanism of Self-Assembled Mixed Micelles in Improving Curcumin Oral Absorption: In Vitro and in Vivo" Colloids Surf. B Biointerfaces (2015) 10.1016/j.colsurfb.2015.05.056
[36]
Yang "Recent Advances in the Application of Vitamin E TPGS for Drug Delivery" Theranostics (2018) 10.7150/thno.22711
[37]
Okassa "Optimization of Iron Oxide Nanoparticles Encapsulation within Poly(d,l-Lactide-Co-Glycolide) Sub-Micron Particles" Eur. J. Pharm. Biopharm. (2007) 10.1016/j.ejpb.2006.12.020
[38]
Mu "A Novel Controlled Release Formulation for the Anticancer Drug Paclitaxel (Taxol®): PLGA Nanoparticles Containing Vitamin E TPGS" J. Control. Release (2003) 10.1016/s0168-3659(02)00320-6
[39]
Kumbhar "D-ɑ-Tocopheryl Polyethylene Glycol Succinate: A Review of Multifarious Applications in Nanomedicines" OpenNano (2022) 10.1016/j.onano.2022.100036
[40]
Danhier "PLGA-Based Nanoparticles: An Overview of Biomedical Applications" J. Control. Release (2012) 10.1016/j.jconrel.2012.01.043
[41]
Mahmoudi "Superparamagnetic Iron Oxide Nanoparticles (SPIONs): Development, Surface Modification and Applications in Chemotherapy" Adv. Drug Deliv. Rev. (2011) 10.1016/j.addr.2010.05.006
[42]
Ghosh "Genotoxicity and Biocompatibility of Superparamagnetic Iron Oxide Nanoparticles: Influence of Surface Modification on Biodistribution, Retention, DNA Damage and Oxidative Stress" Food Chem. Toxicol. (2020) 10.1016/j.fct.2019.110989
[43]
Gaonkar "Garcinol Loaded Vitamin E TPGS Emulsified PLGA Nanoparticles: Preparation, Physicochemical Characterization, in Vitro and in Vivo Studies" Sci. Rep. (2017) 10.1038/s41598-017-00696-6
[44]
"Design of Vitamin E D-α-Tocopheryl Polyethylene Glycol 1000 Succinate-Emulsified Poly (D,L–Lactide–Co-Glycolide) Nanoparticles: Influence of Duration of Ultrasonication Energy" J. Young Pharm. (2011) 10.4103/0975-1483.83754
[45]
Zhang "Doxorubicin-Loaded Star-Shaped Copolymer PLGA-Vitamin E TPGS Nanoparticles for Lung Cancer Therapy" J. Mater. Sci. Mater. Med. (2015) 10.1007/s10856-015-5498-z
[46]
Mei "Carrier-Free Nanodrugs with Efficient Drug Delivery and Release for Cancer Therapy: From Intrinsic Physicochemical Properties to External Modification" Bioact. Mater. (2022)
[47]
Haripriyaa "Pharmacokinetics of Nanoparticles: Current Knowledge, Future Directions and Its Implications in Drug Delivery" Futur. J. Pharm. Sci. (2023) 10.1186/s43094-023-00569-y
[48]
Kim "Stimuli-Responsive Magnetic Nanomicelles as Multifunctional Heat and Cargo Delivery Vehicles" Langmuir (2013) 10.1021/la3044158
[49]
Ai "Magnetite-Loaded Polymeric Micelles as Ultrasensitive Magnetic-Resonance Probes" Adv. Mater. (2005) 10.1002/adma.200401904
[50]
Vidawati "Effects of Sonication Processing on the Behavior of the Synthesis Human Serum Albumin-SPIONs Loaded PLGA Nanoparticles" Adv. Biol. Chem. (2019) 10.4236/abc.2019.96014

Showing 50 of 68 references

Metrics
1
Citations
68
References
Details
Published
Jun 30, 2025
Vol/Issue
12(7)
Pages
715
License
View
Funding
the Department of Science and Technology (DST), India, under the Nanomission program Award: No. SR/NM/NS-1141/2015 (G)
Shiv Nadar Institution of Eminence (Shiv Nadar University), Uttar Pradesh, India Award: No. SR/NM/NS-1141/2015 (G)
Cite This Article
Atul Sudame, Dipak Maity (2025). Unlocking Superior MFH Performance Below Hergt’s Biological Safety Limit: SPION-Based Magnetic Nanoplatforms Deliver High Heating Efficiency at Low AMF. Bioengineering, 12(7), 715. https://doi.org/10.3390/bioengineering12070715